Lactic acid bacteria (LAB) are Gram-positive bacteria and are generally reg
arded as safe (GRAS) organisms. Therefore, LAB could be used for heterologo
us protein secretion and they are good potential candidates as antigen deli
very vehicles. To develop such live vaccines, a better control of protein s
ecretion is required. We developed an efficient secretion system in the mod
el LAB, Lactococcus lactis. Staphylococcal nuclease (Nuc) was used as the r
eporter protein. We first observed that the quantity of secreted Nuc correl
ated with the copy number of the cloning vector. The nuc gene was cloned on
a high-copy number cloning vector and no perturbation of the metabolism of
the secreting strain was observed. Replacement of nuc native promoter by a
strong lactococcal one led to a significant increase of nuc expression. Se
cretion efficiency (SE) of Nuc in L. lactis was low, i.e., only 60% of the
synthesized Nuc was secreted. Insertion of a synthetic propeptide between t
he signal peptide and the mature moiety of Nuc increased the SE of Nuc. On
the basis of these results, we developed a secretion system and we applied
it to the construction of an L. lactis strain which secretes a bovine coron
avirus (BCV) epitope-protein fusion (BCV-Nuc). BCV-Nuc was recognized by bo
th anti-BCV and anti-Nuc antibodies. Secretion of this antigenic fusion is
the first step towards the development of a novel antigen delivery system b
ased on LAB-secreting strains.